Risk minimization measures
| Scientific Name | Brand name | Approval Date | Last Update | Details |
|---|---|---|---|---|
| Macitentan | Opsumit | Details | ||
| Brolucizumab | Beovu | Details | ||
| Erdafitinib | Balversa | Details | ||
| Isatuximab | Sarclisa | Details | ||
| Daptomycin | DACI | Details | ||
| Fingolimod | Olican | Details | ||
| Rivaroxaban | Rivaroxaban SPC | Details | ||
| Agalsidase Beta | Fabrazyme | Details | ||
| Luspatercept | Reblozyl | Details | ||
| Adalimumab | Hyrimoz | Details |
